IL-33 Reporter HEK 293 Cells

Product Unit size Cat. code Docs. Qty. Price

HEK-Blue™ IL-33 Cells

Human IL-33 Reporter Cells

Show product

3-7 x 10e6 cells


IL-33 Reporter Cells

IL-33 signaling pathway
IL-33 signaling in HEK-Blue™ IL-33 Cells

HEK-Blue™ IL-33 cells are designed to detect bioactive interleukin-33 (IL-33) by monitoring the activation of the NF-κB and AP-1 pathways. IL-33 is a pro-inflammatory cytokine that shares structural and functional characteristics with the IL-1 cytokine family. It binds and signals through the IL-1RL1/ IL-1R accessory protein (IL-1RAcP) receptor activating NF-κB and MAP kinases.

More details More details on Interleukin-33


Cell line description:

HEK-Blue™ IL-33 cells were generated by stable transfection of human embryonic kidney HEK293-derived cells with the human IL1RL1 gene. In addition, the TNF-α and the IL-1β responses have been blocked.

Therefore, HEK-Blue™ IL-33 cells respond specifically to IL-33. These cells express an NF-κB/AP-1- inducible SEAP reporter gene.

The binding of human IL-33 to the heterodimeric  IL-1RL1/ IL-1RAcP  on the surface of these cells triggers a signaling cascade leading to the activation of NF-κB and the subsequent production of SEAP.

Levels of SEAP in the supernatant can be easily determined with QUANTI-Blue™ Solution.

Features of HEK-Blue™ IL-33 cells:

  • Fully functional IL-33 signaling pathway
  • Do not respond to human TNF-α
  • Do not respond to human IL-1β
  • Readily assessable SEAP reporter activity
  • Functionally tested and guaranteed mycoplasma-free

Applications of HEK-Blue™ IL-33 cells:

  • Detection of human IL-33
  • Screening of anti-IL-33 antibodies


Cellular response to IL‑33
Cellular response to IL‑33

Dose-response of HEK-Blue™ IL‑33 cells to recombinant hIL‑33.
Cells were stimulated with increasing concentrations of recombinant IL-33. After overnight incubation, the NF-κB/AP-1 response was determined using QUANTI-Blue™ Solution, a SEAP detection reagent, and reading the optical density (OD) at 630 nm. Data are shown as mean ± SEM.

Cell line specificity HEK-Blue IL-33 cells
Cell line specificity HEK-Blue IL-33 cells

Response of HEK‑Blue™ IL‑33 cells to a panel of cytokines.
Cells were stimulated with various human and murine recombinant cytokines: 1 ng/ml of hIL‑33, 10 ng/ml of hIL‑1β, mIL-1β, hIL-2, hIL-4, hIL-17, hIL-18, hIFN-γ, hTNF-α, mTNF-α, or 102 U/ml hIFN-α2a or hIFN-β. After overnight incubation, SEAP activity was assessed using QUANTI-Blue™ Solution. The OD readings at 630 nm are shown as mean ± SEM.

Human IL‑33 signaling inhibition
Human IL‑33 signaling inhibition

Dose-dependent inhibition of HEK-Blue™ IL‑33 cellular response using a neutralizing antibody against hIL‑33.
The anti‑hIL33 antibody was incubated with the cells for 30 minutes prior to the addition of hIL-33 (1 ng/ml). After overnight incubation, SEAP activity in the cell culture supernatant was assessed using QUANTI-Blue™ Solution. Data (shown as mean ± SEM) represent the percentage (%) of maximal reporter activity without the anti-hIL33 antibody.

Back to the top


Antibiotic resistance: blasticidin, hygromycin B, Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

Specificity: Detects human IL-33

Detection range: 0.5 - 100 ng/ml


This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top


  • 1 vial containing 3-7 x 106 cells
  • 2 x 1 ml of HEK-Blue™ Selection (250x concentrate)
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Dry ice shipping Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Back to the top


Interleukin-33 (IL-33; also known as IL-1F11, DVS22, NF-HEV)) is a member of the IL-1/Toll-like receptor cytokine superfamily, a group of cytokines that play important roles in host defense, immune regulation, and inflammation [1, 2].

IL-33 is constitutively expressed in lymphoid tissues, epithelial cells, fibroblasts, mucosal tissues, tumor cells, and vascular tissues [3]. It plays a central role in type 2 innate and adaptive immunity and inflammation, modulating Th2, ILC2 and M2 macrophage responses [2]. It is involved in responses to type 2 infections (e.g. parasites), tissue repair, as well as harmful allergic responses (e.g. asthma) [2].

IL-33 mediates its biological effects through the IL-1R4 receptor (also known as ST2, IL1RL1, IL-33R) and the IL-1R3 accessory protein (also known as IL-1RAcP or IL-1RAP) [2, 4, 5].

Upon ligand binding, IL-1Rs dimerize through their Toll/interleukin-1 resistance (TIR) domains to recruit the MyD88 adaptor protein, which then couples to IL-1R-associated kinases (IRAKs) and tumor necrosis factor receptor-associated factor 6 (TRAF6). This leads to the activation of key transcription factors, including NF-KB, AP-1, and IRFs [2, 4].

IL-33 can function both as a traditional cytokine and as a nuclear factor regulating gene transcription. Following pro-inflammatory stimulation, IL-33 can induce Th2-biased immune responses, such as the production of IL-4, IL-5 and IL-13 [6]. In addition, as IL-33 is constitutively expressed in endothelial and epithelial cells, it can act as an endogenous danger signal, or damage-associated molecular pattern (DAMP; also called alarmins), in response to tissue damage [7, 8].

IL-33 has emerged as a key regulatory cytokine in barrier tissues, making it an important target for inhibition therapy in autoimmune diseases such as inflammatory bowel disease (IBD), rhumatoid arthgritis (RA), asthma, and allergies.


1. Arend W. et al., 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 223:20-38.
2. Mantovani, A., et al., 2019. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. Immunity. 50(4): p. 778-795.
3. Catalan-Dibene, J. et al., 2018. Interleukin 30 to Interleukin 40. J Interferon Cytokine Res. 38(10):423-439.
4. Teufel, L.U., et al., 2022. IL-1 family cytokines as drivers and inhibitors of trained immunity. Cytokine. 150: p. 155773.
5. Gaballa, J.M., et al., 2024. International nomenclature guidelines for the IL-1 family of cytokines and receptors. Nature Immunology. 25(4): p. 581-582.
6. Schiering C. et al., 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature. 513(7519):564-8.
7. Cayrol C. & Girard JP., 2014. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 31-7.
8. Oboki K. et al., 2011. IL-33 and airway inflammation. Allergy Asthma Immunol Res. 3(2): 81–88. 

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top

Notification:  This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty